[pending] FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed B
Pending LLM rewrite. Source: FDA_DRUG D-0385-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Stability Data Does Not Support Expiry Date.
The recalled product
- Product
- FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-016.
- Manufacturer
- HTO Nevada Inc. dba Kirkman
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lot #: 839CP-0016
- Exp. Date 03/31/2026
- 839CP-0017
- Exp. Date 06/30/2026
- 839CP-0018
- Exp. Date 08/31/2026
- 839CP-0019
- Exp. Date 10/31/2026
- 839CP-0020
- Exp. Date 03/31/2027
- 839CP-0021
- Exp. Date 07/31/2027
- 839CP-0022
- Exp.Date 11/30/2027
- 839CP-0023
- Exp. Date 02/29/2028
- 839CP-0024
- Exp. Date 07/31/2028.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27